Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
66.8M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
98.2K
-
Shares change
-
+88.6K
-
Total reported value, excl. options
-
$7.24M
-
Value change
-
+$6.54M
-
Number of buys
-
2
-
Price
-
$74.33
Significant Holders of Nuvalent, Inc. - Class A Stock (NUVL) as of Q4 2023
2 filings reported holding NUVL - Nuvalent, Inc. - Class A Stock as of Q4 2023.
Nuvalent, Inc. - Class A Stock (NUVL) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 98.2K shares
of 66.8M outstanding shares and own 0.15% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (20M shares), FMR LLC (8.73M shares), Paradigm Biocapital Advisors LP (3.86M shares), Bain Capital Life Sciences Investors, LLC (3.58M shares), VANGUARD GROUP INC (3.34M shares), PERCEPTIVE ADVISORS LLC (2.92M shares), BlackRock Inc. (2.72M shares), Fairmount Funds Management LLC (1.92M shares), STATE STREET CORP (1.7M shares), and COMMODORE CAPITAL LP (1.33M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.